Johnson & Johnson launched a new late-stage trial in Britain on Monday to test a two-dose regimen of its experimental COVID-19 vaccine among thousands of volunteers, as the U.S. drugmaker expands its...
from NDTV News - Latest https://ift.tt/38NtXP0
via
